Register      Login
Australian Health Review Australian Health Review Society
Journal of the Australian Healthcare & Hospitals Association

Articles citing this paper

Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience

Sarah Howard A F , Ian A. Scott B , Hong Ju C , Liam McQueen A and Paul A. Scuffham D E
+ Author Affiliations
- Author Affiliations

A Healthcare Evaluation and Assessment of Technology, Healthcare Improvement Unit, Clinical Excellence Division, Queensland Department of Health, Level 2, 15 Butterfield Street, Herston, Qld 4006, Australia. Email: Liam.McQueen@health.qld.gov.au

B Department of Internal Medicine and Clinical Epidemiology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia. Email: ian_scott@health.qld.gov.au

C Agency for Care Effectiveness, Ministry of Health, 16 College Road, Singapore. Email: hongju04@yahoo.com

D Menzies Health Institute Queensland, Griffith University, Nathan, Brisbane, Qld 4111, Australia. Email: p.scuffham@griffith.edu.au

E Centre for Applied Health Economics, Griffith University, Nathan, Brisbane, Qld 4111, Australia.

F Corresponding author. Email: sarah.howard@health.qld.gov.au

Australian Health Review 43(5) 591-599 https://doi.org/10.1071/AH18042
Submitted: 1 March 2018  Accepted: 9 August 2018   Published: 12 September 2018



14 articles found in Crossref database.

The role of Iran's context for the development of health technology assessment: challenges and solutions
Behzadifar Meysam, Behzadifar Masoud, Saran Maryam, Shahabi Saeed, Bakhtiari Ahad, Azari Samad, Bragazzi Nicola Luigi
Health Economics Review. 2023 13(1).
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain)
Gasol Montse, Paco Noelia, Guarga Laura, Bosch Josep Àngel, Pontes Caridad, Obach Mercè
Journal of Clinical Medicine. 2022 11(5). p.1353
Assessing Progress Towards Sustainability (2022)
Labianca Claudia, De Gisi Sabino, Notarnicola Michele
Multiple Criteria Decision Making (2021)
Erol Eren, Yilmaz Beyza Özlem, Karadayi Melis Almula, Tozan Hakan
Linking infection control to clinical management of infections to overcome antimicrobial resistance
Tacconelli E.
Journal of Hospital Infection. 2021 114 p.1
Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review
Ahumada-Canale Antonio, Jeet Varinder, Bilgrami Anam, Seil Elizabeth, Gu Yuanyuan, Cutler Henry
Social Science & Medicine. 2023 322 p.115790
The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review
Gongora-Salazar Pamela, Rocks Stephen, Fahr Patrick, Rivero-Arias Oliver, Tsiachristas Apostolos
Value in Health. 2023 26(5). p.780
Lane Choice Behavior at Toll Plaza Under Mixed Traffic Conditions Using TODIM Method: A Case Study
Bari Chintaman Santosh, Chopde Rohit, Dhamaniya Ashish
Transportation in Developing Economies. 2022 8(2).
A Rapid Literature Review of Multi-Criteria Decision Support Methods in the Context of One Health for All-Hazards Threat Prioritization
Zhao Jiawei, Smith Tiffany, Lavigne Melissa, Aenishaenslin Cécile, Cox Ruth, Fazil Aamir, Johnson Ana, Sanchez Javier, Hermant Benoit
Frontiers in Public Health. 2022 10
Quantifying stakeholders’ preference for implantable medical devices in China: a discrete choice experiment
Wan Bin, Shen Jiaojie, Chen Jiali, Weng Linjia, Zhao Peng, Deng Yunfei, Zhang Lingli, Zhang Feiyi, Wang Yingpeng, Li Xin, Chang Feng, Ding Haixia, Lu Yun
International Journal of Technology Assessment in Health Care. 2024 40(1).
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
Jakab Ivett, Németh Bertalan, Elezbawy Baher, Karadayı Melis Almula, Tozan Hakan, Aydın Sabahattin, Shen Jie, Kaló Zoltán
Frontiers in Pharmacology. 2020 11
Time to inclusion in clinical guidance documents for non-oncological orphan drugs and biologics with expedited FDA designations: a retrospective survival analysis
Rodriguez Ryan, Brunner Rachel, Spencer Samantha, Qato Dima M
BMJ Open. 2021 11(12). p.e057744
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study
de Andrés-Nogales Fernando, Casado Miguel Ángel, Trillo José Luis, Ruiz-Moreno José María, Martínez-Sesmero José Manuel, Peralta Gemma, Poveda José Luis, Ortiz Pere, Ignacio Emilio, Zarranz-Ventura Javier, Udaondo Patricia, Mur Carlos, Álvarez Eloísa, Cervera Enrique, Martínez Mercedes, Llorente Iñaki, Zulueta Jacinto, Rodríguez-Maqueda Mariano, García-Layana Alfredo, Martínez-Olmos José
PharmacoEconomics - Open. 2020 4(4). p.615
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Godman Brian, Hill Andrew, Simoens Steven, Selke Gisbert, Selke Krulichová Iva, Zampirolli Dias Carolina, Martin Antony P, Oortwijn Wija, Timoney Angela, Gustafsson Lars L, Voncina Luka, Kwon Hye-Young, Gulbinovic Jolanta, Gotham Dzintars, Wale Janet, Cristina Da Silva Wânia, Bochenek Tomasz, Allocati Eleonora, Kurdi Amanj, Ogunleye Olayinka O., Meyer Johanna C, Hoxha Iris, Malaj Admir, Hierländer Christian, Sauermann Robert, Hamelinck Wouter, Petrova Guenka, Laius Ott, Langner Irene, Yfantopoulos John, Joppi Roberta, Jakupi Arianit, Greiciute-Kuprijanov Ieva, Vella Bonanno Patricia, Piepenbrink Jf (Hans), de Valk Vincent, Wladysiuk Magdalene, Marković-Peković Vanda, Mardare Ileana, Fürst Jurij, Tomek Dominik, Obach Cortadellas Mercè, Zara Corinne, Pontes Caridad, McTaggart Stuart, Laba Tracey-Lea, Melien Øyvind, Wong-Rieger Durhane, Bae SeungJin, Hill Ruaraidh
Expert Review of Pharmacoeconomics & Outcomes Research. 2021 21(4). p.527

Committee on Publication Ethics


Abstract Supplementary MaterialSupplementary Material (143 KB) Export Citation